PMVK drives hepatocarcinogenesis via SP1 phosphorylation–mediated lipid metabolic reprogramming

Journal:

Science Advances

Published:

2026-06-26

DOI:

10.1126/sciadv.aed8866

Affiliations:

6

Authors:

7

Go to article

Institutions	Authors	Share
The Fifth Affiliated Hospital, SYSU, China	5.600000	0.80
MOE Key Laboratory for Regenerative Medicine, China	1.000000	0.14
The First People's Hospital of Kashgar, China	0.200000	0.03
State Key Laboratory of Anti-Infective Drug Discovery and Development, China	0.200000	0.03